Imagine a woman being forced to swallow pills meant to end a pregnancy—pills her boyfriend ordered online without ever seeing a doctor. That nightmare is now at the heart of a legal battle that could change how millions access abortion medication.
More than 100 Republican lawmakers have fired a direct challenge at the Supreme Court. They want the justices to reinstate in-person dispensing requirements for the abortion drug mifepristone, warning that current policies have enabled coercion and even forced ingestion.
The lawmakers’ amicus brief, backed by Senate Majority Leader John Thune and House Speaker Mike Johnson, throws its weight behind Louisiana’s fight. At stake: whether abortion pills can continue to be mailed without face-to-face medical oversight.
Central to their argument are chilling stories. One woman, Rosalie Markezich, says her boyfriend ordered mifepristone from a California doctor and then pressured her to take it. The brief insists that if she had visited a clinic in person, her boyfriend never could have obtained the drugs.
Another case involves a Louisiana mother who reportedly ordered abortion pills online for her teenage daughter—leading to a medical emergency. Yet another alleges a man secretly slipped the drugs to a pregnant woman without her knowledge.
Lawmakers argue that these horrors are a direct result of relaxed federal rules. The Biden-era FDA policy removed the in-person requirement from its Risk Evaluation and Mitigation Strategy, opening the door for online prescriptions and mail-order delivery.
Senator Bill Cassidy didn't mince words: “Chemical abortion drugs kill innocent children and put mothers’ lives at risk. Safeguards against coercion, like the in-person dispensing requirement, must be reinstated immediately.”
The legal clash has already reached a fever pitch. The 5th U.S. Circuit Court of Appeals sided with Louisiana, restoring the in-person requirement while litigation continues. Now the drug manufacturers, Danco Laboratories and GenBioPro, have filed emergency appeals with the Supreme Court.
The manufacturers warn of “immediate confusion and upheaval.” They say clinics, pharmacies, and patients are scrambling to navigate a rapidly shifting landscape. Mail-order access, relied on for years, could vanish overnight.
Lawmakers counter that the FDA overstepped its authority, pointing to the Comstock Act—a 19th-century law that bans mailing items “intended for producing abortion.” They argue the agency relied on weak safety data and weakened adverse-event reporting to justify expanded access.
The brief also highlights medical dangers: over 10% of women experience complications like infection or hemorrhaging. Without in-person visits, doctors can’t screen for ectopic pregnancies or spot signs of abuse.
The Supreme Court now holds the key. Will it block the 5th Circuit’s ruling and preserve mail-order access, or let the in-person requirement stand? The outcome will determine whether abortion pills remain widely available or are locked behind a doctor’s door.
“There are legitimate concerns about these drugs putting women and girls at significant risk,” said Senator Thune. “I urge the Supreme Court to reinstate the safety guardrails that were in place before the Biden administration.”
